Phase I drug-food interaction trial of tivantinib.

Trial Profile

Phase I drug-food interaction trial of tivantinib.

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Apr 2012

At a glance

  • Drugs Tivantinib (Primary)
  • Indications Colorectal cancer; Gastric cancer; Germ cell and embryonal neoplasms; Liver cancer; Non-small cell lung cancer; Pancreatic cancer; Renal cancer; Soft tissue sarcoma
  • Focus Pharmacokinetics
  • Sponsors Daiichi Sankyo Europe
  • Most Recent Events

    • 04 Apr 2012 Results presented at the 103rd Annual Meeting of the American Association for Cancer Research.
    • 31 Mar 2012 New trial record
    • 29 Mar 2012 Results will be presented at AACR-2012 according to an ArQule media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top